LAPTM4B-35 Protein Is a Weak Tumor-Associated Antigen Candidate

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2013.1427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

PfRON3 Is an Erythrocyte-Binding Protein and a Potential Blood-Stage Vaccine Candidate Antigen

Malaria Journal
ParasitologyInfectious Diseases
2014English

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer

PLoS ONE
Multidisciplinary
2014English

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2012English

LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer

Oncotarget
Oncology
2016English

Receptor Protein-Tyrosine Phosphatase Gamma Is a Candidate Tumor Suppressor Gene at Human Chromosome Region 3p21.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

PASD1, a DLBCL-associated Cancer Testis Antigen and Candidate for Lymphoma Immunotherapy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation

Clinical Cancer Research
Cancer ResearchOncology
2019English

RALP1 Is a Rhoptry Neck Erythrocyte-Binding Protein of Plasmodium Falciparum Merozoites and a Potential Blood-Stage Vaccine Candidate Antigen

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy